Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy

• Published in: Scientific reports Vol. 12; no. 1; p. 11310
• Main Authors: Mirhadi, Elaheh, Mashreghi, Mohammad, Askarizadeh, Anis, Mehrabian, Amin, Alavizadeh, Seyedeh Hoda, Arabi, Leila, Badiee, Ali, Jaafari, Mahmoud Reza
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 04-07-2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/154; 631/67; 631/92; 639/638; 692/308/153; 692/699/67; Acids; Cancer therapies; Cardiotoxicity; Cholesterol; Colon; Doxorubicin; Drug delivery systems; Glutathione; Humanities and Social Sciences; Hydrogen peroxide; Liposomes; Molecular weight; multidisciplinary; Oxidation; pH effects; Pharmaceuticals; Phase transitions; Science; Science (multidisciplinary); Sodium bicarbonate; Tumors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-15239-x

In this study redox-sensitive (RS) liposomes manufactured using 10,10′-diselanediylbis decanoic acid (DDA), an organoselenium RS compound, to enhance the therapeutic performance of doxorubicin (Dox). The DDA structure was confirmed by 1H NMR and LC–MS/MS. Various liposomal formulations (33 formulations) were prepared using DOPE, Egg PC, and DOPC with Tm ˂ 0 and DDA. Some formulations had mPEG
2000
-DSPE and cholesterol. After extrusion, the external phase was exchanged with sodium bicarbonate to create a pH gradient. Then, Dox was remotely loaded into liposomes. The optimum formulations indicated a burst release of 30% in the presence of 0.1% hydrogen peroxide at pH 6.5, thanks to the redox-sensitive role of DDA moieties; conversely, Caelyx (PEGylated liposomal Dox) showed negligible release at this condition. RS liposomes consisting of DOPE/Egg PC/DDA at 37.5 /60/2.5% molar ratio, efficiently inhibited C26 tumors among other formulations. The release of Dox from RS liposomes in the TME through the DDA link fracture triggered by ROS or glutathione is seemingly the prerequisite for the formulations to exert their therapeutic action. These findings suggest the potential application of such intelligent formulations in the treatment of various malignancies where the TME redox feature could be exploited to achieve an improved therapeutic response.